cbdMD, Inc. (AMEX: YCBD) Stock Competitors & Peer Comparison

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TAK has a market cap of 55.5B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TAK trades at $17.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TAK's P/E ratio is 12.55. In terms of profitability, YCBD's ROE is -0.34%, compared to TAK's ROE of +0.02%. Regarding short-term risk, YCBD is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check TAK's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, HLN has a market cap of 44.2B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while HLN trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas HLN's P/E ratio is 25.11. In terms of profitability, YCBD's ROE is -0.34%, compared to HLN's ROE of +0.17%. Regarding short-term risk, YCBD is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check HLN's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TEVA has a market cap of 41.2B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TEVA trades at $35.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TEVA's P/E ratio is 12.06. In terms of profitability, YCBD's ROE is -0.34%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, YCBD is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check TEVA's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, VTRS has a market cap of 19.1B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while VTRS trades at $16.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas VTRS's P/E ratio is 6.52. In terms of profitability, YCBD's ROE is -0.34%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, YCBD is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check VTRS's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ITCI trades at $131.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ITCI's P/E ratio is -180.64. In terms of profitability, YCBD's ROE is -0.34%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, YCBD is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check ITCI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CTLT trades at $63.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CTLT's P/E ratio is -27.84. In terms of profitability, YCBD's ROE is -0.34%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, YCBD is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check CTLT's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ELAN has a market cap of 11B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ELAN trades at $22.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ELAN's P/E ratio is 20.86. In terms of profitability, YCBD's ROE is -0.34%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, YCBD is less volatile compared to ELAN. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ELAN's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, RDY has a market cap of 10.2B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while RDY trades at $12.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas RDY's P/E ratio is 20.01. In terms of profitability, YCBD's ROE is -0.34%, compared to RDY's ROE of +0.09%. Regarding short-term risk, YCBD is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check RDY's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, LNTH has a market cap of 6.6B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while LNTH trades at $100.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas LNTH's P/E ratio is 16.97. In terms of profitability, YCBD's ROE is -0.34%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, YCBD is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check LNTH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, AMRX has a market cap of 5.8B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while AMRX trades at $18.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas AMRX's P/E ratio is 20.16. In terms of profitability, YCBD's ROE is -0.34%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, YCBD is more volatile compared to AMRX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check AMRX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, INDV has a market cap of 4.8B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while INDV trades at $38.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas INDV's P/E ratio is 10.64. In terms of profitability, YCBD's ROE is -0.34%, compared to INDV's ROE of -2.16%. Regarding short-term risk, YCBD is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check INDV's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while SUPN trades at $47.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas SUPN's P/E ratio is 15.57. In terms of profitability, YCBD's ROE is -0.34%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, YCBD is more volatile compared to SUPN. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check SUPN's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, RGC has a market cap of 2.7B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while RGC trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas RGC's P/E ratio is -380.99. In terms of profitability, YCBD's ROE is -0.34%, compared to RGC's ROE of -2.32%. Regarding short-term risk, YCBD is less volatile compared to RGC. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check RGC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, BHC has a market cap of 2.3B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while BHC trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas BHC's P/E ratio is 1.59. In terms of profitability, YCBD's ROE is -0.34%, compared to BHC's ROE of +0.89%. Regarding short-term risk, YCBD is less volatile compared to BHC. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check BHC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while DCPH trades at $25.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas DCPH's P/E ratio is -11.58. In terms of profitability, YCBD's ROE is -0.34%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, YCBD is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check DCPH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, HCM has a market cap of 2.2B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while HCM trades at $12.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas HCM's P/E ratio is 4.69. In terms of profitability, YCBD's ROE is -0.34%, compared to HCM's ROE of +0.01%. Regarding short-term risk, YCBD is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check HCM's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while AVDL trades at $21.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, YCBD's ROE is -0.34%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, YCBD is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check AVDL's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while EMBCV trades at $33.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas EMBCV's P/E ratio is N/A. In terms of profitability, YCBD's ROE is -0.34%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, YCBD is less volatile compared to EMBCV. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check EMBCV's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while DVAX trades at $15.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas DVAX's P/E ratio is -41.89. In terms of profitability, YCBD's ROE is -0.34%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, YCBD is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check DVAX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ANIP has a market cap of 1.8B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ANIP trades at $78.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ANIP's P/E ratio is 9.52. In terms of profitability, YCBD's ROE is -0.34%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, YCBD is less volatile compared to ANIP. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ANIP's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, PRGO has a market cap of 1.8B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while PRGO trades at $12.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas PRGO's P/E ratio is 5.13. In terms of profitability, YCBD's ROE is -0.34%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, YCBD is more volatile compared to PRGO. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check PRGO's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TARO trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TARO's P/E ratio is 30.05. In terms of profitability, YCBD's ROE is -0.34%, compared to TARO's ROE of +0.03%. Regarding short-term risk, YCBD is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check TARO's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, HROW has a market cap of 1.5B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while HROW trades at $40.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas HROW's P/E ratio is 449.33. In terms of profitability, YCBD's ROE is -0.34%, compared to HROW's ROE of -0.34%. Regarding short-term risk, YCBD is more volatile compared to HROW. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check HROW's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while PAHC trades at $34.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas PAHC's P/E ratio is 11.70. In terms of profitability, YCBD's ROE is -0.34%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, YCBD is less volatile compared to PAHC. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check PAHC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ALVO has a market cap of 1.3B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ALVO trades at $3.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ALVO's P/E ratio is -11.21. In terms of profitability, YCBD's ROE is -0.34%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, YCBD is more volatile compared to ALVO. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check ALVO's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ETON has a market cap of 1.2B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ETON trades at $44.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ETON's P/E ratio is -637.14. In terms of profitability, YCBD's ROE is -0.34%, compared to ETON's ROE of -0.06%. Regarding short-term risk, YCBD is more volatile compared to ETON. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check ETON's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CRON has a market cap of 1.2B. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CRON trades at $3.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CRON's P/E ratio is 29.44. In terms of profitability, YCBD's ROE is -0.34%, compared to CRON's ROE of +0.06%. Regarding short-term risk, YCBD is more volatile compared to CRON. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check CRON's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, PCRX has a market cap of 984.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while PCRX trades at $25.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas PCRX's P/E ratio is 9.62. In terms of profitability, YCBD's ROE is -0.34%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, YCBD is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check PCRX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, COLL has a market cap of 955.8M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while COLL trades at $29.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas COLL's P/E ratio is 3.70. In terms of profitability, YCBD's ROE is -0.34%, compared to COLL's ROE of +0.16%. Regarding short-term risk, YCBD is less volatile compared to COLL. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check COLL's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while PETQ trades at $30.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas PETQ's P/E ratio is 83.73. In terms of profitability, YCBD's ROE is -0.34%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, YCBD is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check PETQ's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, AMPH has a market cap of 916.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while AMPH trades at $20.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas AMPH's P/E ratio is 7.09. In terms of profitability, YCBD's ROE is -0.34%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, YCBD is less volatile compared to AMPH. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check AMPH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, IRWD has a market cap of 711.1M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while IRWD trades at $4.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas IRWD's P/E ratio is 5.54. In terms of profitability, YCBD's ROE is -0.34%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, YCBD is more volatile compared to IRWD. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check IRWD's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, EVO has a market cap of 710.5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while EVO trades at $2.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas EVO's P/E ratio is -2.82. In terms of profitability, YCBD's ROE is -0.34%, compared to EVO's ROE of -0.24%. Regarding short-term risk, YCBD is more volatile compared to EVO. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check EVO's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while BDSI trades at $5.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas BDSI's P/E ratio is 6.82. In terms of profitability, YCBD's ROE is -0.34%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, YCBD is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check BDSI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TLRY has a market cap of 511.1M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TLRY trades at $4.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TLRY's P/E ratio is -7.21. In terms of profitability, YCBD's ROE is -0.34%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, YCBD is more volatile compared to TLRY. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check TLRY's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, EOLS has a market cap of 499.8M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while EOLS trades at $7.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas EOLS's P/E ratio is -24.04. In terms of profitability, YCBD's ROE is -0.34%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, YCBD is less volatile compared to EOLS. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check EOLS's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, AQST has a market cap of 494.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while AQST trades at $3.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas AQST's P/E ratio is -6.46. In terms of profitability, YCBD's ROE is -0.34%, compared to AQST's ROE of +1.91%. Regarding short-term risk, YCBD is more volatile compared to AQST. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check AQST's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, KMDA has a market cap of 419.4M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while KMDA trades at $7.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas KMDA's P/E ratio is 20.77. In terms of profitability, YCBD's ROE is -0.34%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, YCBD is more volatile compared to KMDA. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check KMDA's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CGC has a market cap of 409.5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CGC trades at $0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CGC's P/E ratio is -0.58. In terms of profitability, YCBD's ROE is -0.34%, compared to CGC's ROE of -0.31%. Regarding short-term risk, YCBD is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check CGC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TKNO has a market cap of 346.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TKNO trades at $6.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TKNO's P/E ratio is -20.84. In terms of profitability, YCBD's ROE is -0.34%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, YCBD is less volatile compared to TKNO. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check TKNO's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ALIM trades at $5.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ALIM's P/E ratio is 5.28. In terms of profitability, YCBD's ROE is -0.34%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, YCBD is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check ALIM's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while LNDC trades at $8.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas LNDC's P/E ratio is -4.04. In terms of profitability, YCBD's ROE is -0.34%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, YCBD is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check LNDC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, EMBC has a market cap of 262.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while EMBC trades at $4.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas EMBC's P/E ratio is 1.70. In terms of profitability, YCBD's ROE is -0.34%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, YCBD is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check EMBC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ORGO has a market cap of 239.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ORGO trades at $1.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ORGO's P/E ratio is 62.00. In terms of profitability, YCBD's ROE is -0.34%, compared to ORGO's ROE of -0.27%. Regarding short-term risk, YCBD is less volatile compared to ORGO. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ORGO's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TYHT trades at $11.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TYHT's P/E ratio is -1.61. In terms of profitability, YCBD's ROE is -0.34%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, YCBD is less volatile compared to TYHT. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check TYHT's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, SIGA has a market cap of 218.8M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while SIGA trades at $3.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas SIGA's P/E ratio is 11.30. In terms of profitability, YCBD's ROE is -0.34%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, YCBD is more volatile compared to SIGA. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check SIGA's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, LFCR has a market cap of 187.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while LFCR trades at $5.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas LFCR's P/E ratio is -4.68. In terms of profitability, YCBD's ROE is -0.34%, compared to LFCR's ROE of -1.95%. Regarding short-term risk, YCBD is less volatile compared to LFCR. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check LFCR's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ACB has a market cap of 185.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ACB trades at $2.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ACB's P/E ratio is -6.10. In terms of profitability, YCBD's ROE is -0.34%, compared to ACB's ROE of -0.21%. Regarding short-term risk, YCBD is more volatile compared to ACB. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check ACB's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while REPH trades at $2.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas REPH's P/E ratio is -8.04. In terms of profitability, YCBD's ROE is -0.34%, compared to REPH's ROE of -0.22%. Regarding short-term risk, YCBD is less volatile compared to REPH. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check REPH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, DERM has a market cap of 177M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while DERM trades at $6.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas DERM's P/E ratio is -17.38. In terms of profitability, YCBD's ROE is -0.34%, compared to DERM's ROE of -0.36%. Regarding short-term risk, YCBD is less volatile compared to DERM. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check DERM's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CRDL has a market cap of 163.7M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CRDL trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CRDL's P/E ratio is -5.05. In terms of profitability, YCBD's ROE is -0.34%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, YCBD is less volatile compared to CRDL. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check CRDL's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while THTX trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas THTX's P/E ratio is -28.83. In terms of profitability, YCBD's ROE is -0.34%, compared to THTX's ROE of +0.17%. Regarding short-term risk, YCBD is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check THTX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ASRT trades at $23.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ASRT's P/E ratio is -7.10. In terms of profitability, YCBD's ROE is -0.34%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, YCBD is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check ASRT's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, OGI has a market cap of 139.4M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while OGI trades at $0.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas OGI's P/E ratio is -3.81. In terms of profitability, YCBD's ROE is -0.34%, compared to OGI's ROE of -0.07%. Regarding short-term risk, YCBD is more volatile compared to OGI. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check OGI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CPIX has a market cap of 116.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CPIX trades at $7.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CPIX's P/E ratio is -19.50. In terms of profitability, YCBD's ROE is -0.34%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, YCBD is less volatile compared to CPIX. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check CPIX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while SCTL trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas SCTL's P/E ratio is -7.86. In terms of profitability, YCBD's ROE is -0.34%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, YCBD is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check SCTL's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while PROC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas PROC's P/E ratio is 1.53. In terms of profitability, YCBD's ROE is -0.34%, compared to PROC's ROE of -2.22%. Regarding short-term risk, YCBD is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check PROC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while OPTN trades at $9.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas OPTN's P/E ratio is -4.42. In terms of profitability, YCBD's ROE is -0.34%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, YCBD is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check OPTN's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ZOM trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ZOM's P/E ratio is -1.62. In terms of profitability, YCBD's ROE is -0.34%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, YCBD is less volatile compared to ZOM. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ZOM's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ZYBT has a market cap of 89.6M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ZYBT trades at $1.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ZYBT's P/E ratio is -8.59. In terms of profitability, YCBD's ROE is -0.34%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, YCBD is less volatile compared to ZYBT. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ZYBT's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while GRVI trades at $4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas GRVI's P/E ratio is 26.05. In terms of profitability, YCBD's ROE is -0.34%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, YCBD is less volatile compared to GRVI. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check GRVI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ZYNE trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, YCBD's ROE is -0.34%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, YCBD is less volatile compared to ZYNE. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ZYNE's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while SSIC trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas SSIC's P/E ratio is 11.93. In terms of profitability, YCBD's ROE is -0.34%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, YCBD is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check SSIC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while VLNS trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas VLNS's P/E ratio is -1.03. In terms of profitability, YCBD's ROE is -0.34%, compared to VLNS's ROE of N/A. Regarding short-term risk, YCBD is more volatile compared to VLNS. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check VLNS's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, BGM has a market cap of 60.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while BGM trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas BGM's P/E ratio is -1.04. In terms of profitability, YCBD's ROE is -0.34%, compared to BGM's ROE of -0.07%. Regarding short-term risk, YCBD is more volatile compared to BGM. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check BGM's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while DRRX trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas DRRX's P/E ratio is -4.44. In terms of profitability, YCBD's ROE is -0.34%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, YCBD is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check DRRX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, INCR has a market cap of 58M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while INCR trades at $0.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas INCR's P/E ratio is -2.26. In terms of profitability, YCBD's ROE is -0.34%, compared to INCR's ROE of -0.09%. Regarding short-term risk, YCBD is more volatile compared to INCR. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check INCR's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while JUPW trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas JUPW's P/E ratio is -2.41. In terms of profitability, YCBD's ROE is -0.34%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, YCBD is less volatile compared to JUPW. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check JUPW's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while QLI trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas QLI's P/E ratio is -4.92. In terms of profitability, YCBD's ROE is -0.34%, compared to QLI's ROE of -0.16%. Regarding short-term risk, YCBD is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check QLI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while HEXO trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas HEXO's P/E ratio is -0.26. In terms of profitability, YCBD's ROE is -0.34%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, YCBD is less volatile compared to HEXO. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check HEXO's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TLPH has a market cap of 29.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TLPH trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TLPH's P/E ratio is -4.61. In terms of profitability, YCBD's ROE is -0.34%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, YCBD is more volatile compared to TLPH. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check TLPH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, RMTI has a market cap of 28.5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while RMTI trades at $7.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas RMTI's P/E ratio is -6.89. In terms of profitability, YCBD's ROE is -0.34%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, YCBD is more volatile compared to RMTI. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check RMTI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, AYTU has a market cap of 25.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while AYTU trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas AYTU's P/E ratio is -1.23. In terms of profitability, YCBD's ROE is -0.34%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, YCBD is more volatile compared to AYTU. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check AYTU's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, TXMD has a market cap of 24M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while TXMD trades at $2.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas TXMD's P/E ratio is 105.45. In terms of profitability, YCBD's ROE is -0.34%, compared to TXMD's ROE of +0.01%. Regarding short-term risk, YCBD is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check TXMD's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CYTH trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CYTH's P/E ratio is -0.80. In terms of profitability, YCBD's ROE is -0.34%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, YCBD is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check CYTH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while EVOK trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas EVOK's P/E ratio is -7.97. In terms of profitability, YCBD's ROE is -0.34%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, YCBD is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check EVOK's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, BFRIW has a market cap of 17M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while BFRIW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas BFRIW's P/E ratio is -0.03. In terms of profitability, YCBD's ROE is -0.34%, compared to BFRIW's ROE of -4.77%. Regarding short-term risk, YCBD is less volatile compared to BFRIW. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check BFRIW's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, OPTH has a market cap of 16.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while OPTH trades at $5.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas OPTH's P/E ratio is -18.56. In terms of profitability, YCBD's ROE is -0.34%, compared to OPTH's ROE of -0.94%. Regarding short-term risk, YCBD is more volatile compared to OPTH. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check OPTH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ACRX trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ACRX's P/E ratio is -0.31. In terms of profitability, YCBD's ROE is -0.34%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, YCBD is less volatile compared to ACRX. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ACRX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, COSM has a market cap of 12.7M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while COSM trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas COSM's P/E ratio is -0.38. In terms of profitability, YCBD's ROE is -0.34%, compared to COSM's ROE of -0.96%. Regarding short-term risk, YCBD is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check COSM's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while AGRX trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas AGRX's P/E ratio is -0.89. In terms of profitability, YCBD's ROE is -0.34%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, YCBD is more volatile compared to AGRX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check AGRX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while NLTX trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas NLTX's P/E ratio is -0.28. In terms of profitability, YCBD's ROE is -0.34%, compared to NLTX's ROE of -0.38%. Regarding short-term risk, YCBD is more volatile compared to NLTX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check NLTX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while LCI trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas LCI's P/E ratio is -0.04. In terms of profitability, YCBD's ROE is -0.34%, compared to LCI's ROE of +1.66%. Regarding short-term risk, YCBD is less volatile compared to LCI. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check LCI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ADMP trades at $0.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ADMP's P/E ratio is -0.08. In terms of profitability, YCBD's ROE is -0.34%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, YCBD is less volatile compared to ADMP. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check ADMP's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, GELS has a market cap of 5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while GELS trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas GELS's P/E ratio is -1.09. In terms of profitability, YCBD's ROE is -0.34%, compared to GELS's ROE of -0.25%. Regarding short-term risk, YCBD is less volatile compared to GELS. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check GELS's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while MNK trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas MNK's P/E ratio is -0.44. In terms of profitability, YCBD's ROE is -0.34%, compared to MNK's ROE of -0.26%. Regarding short-term risk, YCBD is less volatile compared to MNK. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check MNK's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while FLGC trades at $7.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas FLGC's P/E ratio is -0.19. In terms of profitability, YCBD's ROE is -0.34%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, YCBD is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check FLGC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CPHI has a market cap of 3.6M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CPHI trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CPHI's P/E ratio is -1.76. In terms of profitability, YCBD's ROE is -0.34%, compared to CPHI's ROE of -0.19%. Regarding short-term risk, YCBD is less volatile compared to CPHI. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check CPHI's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, UPC has a market cap of 3.5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while UPC trades at $5.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas UPC's P/E ratio is -0.69. In terms of profitability, YCBD's ROE is -0.34%, compared to UPC's ROE of -0.03%. Regarding short-term risk, YCBD is less volatile compared to UPC. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check UPC's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, SBFM has a market cap of 2.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while SBFM trades at $1.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas SBFM's P/E ratio is -0.20. In terms of profitability, YCBD's ROE is -0.34%, compared to SBFM's ROE of -0.26%. Regarding short-term risk, YCBD is less volatile compared to SBFM. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check SBFM's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, SHPH has a market cap of 2.6M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while SHPH trades at $4.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas SHPH's P/E ratio is -0.20. In terms of profitability, YCBD's ROE is -0.34%, compared to SHPH's ROE of -4.08%. Regarding short-term risk, YCBD is more volatile compared to SHPH. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check SHPH's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while PLXP trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas PLXP's P/E ratio is -0.22. In terms of profitability, YCBD's ROE is -0.34%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, YCBD is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check PLXP's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, SNOA has a market cap of 2.4M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while SNOA trades at $1.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas SNOA's P/E ratio is -1.22. In terms of profitability, YCBD's ROE is -0.34%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, YCBD is less volatile compared to SNOA. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check SNOA's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while ATNX trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas ATNX's P/E ratio is -0.02. In terms of profitability, YCBD's ROE is -0.34%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, YCBD is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check ATNX's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while PROCW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas PROCW's P/E ratio is N/A. In terms of profitability, YCBD's ROE is -0.34%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, YCBD is more volatile compared to PROCW. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check PROCW's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, RDHL has a market cap of 1.9M. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while RDHL trades at $0.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas RDHL's P/E ratio is 0.12. In terms of profitability, YCBD's ROE is -0.34%, compared to RDHL's ROE of +57.40%. Regarding short-term risk, YCBD is less volatile compared to RDHL. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check RDHL's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, YCBD-PA has a market cap of 928.2K. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while YCBD-PA trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas YCBD-PA's P/E ratio is -2.69. In terms of profitability, YCBD's ROE is -0.34%, compared to YCBD-PA's ROE of -0.34%. Regarding short-term risk, YCBD is less volatile compared to YCBD-PA. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check YCBD-PA's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, CYTHW has a market cap of 928K. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while CYTHW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas CYTHW's P/E ratio is N/A. In terms of profitability, YCBD's ROE is -0.34%, compared to CYTHW's ROE of -7.30%. Regarding short-term risk, YCBD is more volatile compared to CYTHW. This indicates higher risk in terms of short-term price fluctuations for YCBD.Check CYTHW's competition here

cbdMD, Inc. (AMEX: YCBD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD stands at 5.9M. In comparison, LSDI has a market cap of 906.9K. Regarding current trading prices, YCBD is priced at $0.57 on the AMEX, while LSDI trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD currently has a P/E ratio of -1.38, whereas LSDI's P/E ratio is -0.07. In terms of profitability, YCBD's ROE is -0.34%, compared to LSDI's ROE of +181.47%. Regarding short-term risk, YCBD is less volatile compared to LSDI. This indicates lower risk in terms of short-term price fluctuations for YCBD.Check LSDI's competition here